<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>16193437</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Mesa-Toledo, E</dc:author>
<dc:author>Miserachs-García, S</dc:author>
<dc:author>Castillo-Campillo, L</dc:author>
<dc:author>Arruga-Ginebreda, J</dc:author>
<dc:description xml:lang="en">CLINICAL CASE A 46-year-old man, treated with peginterferon alpha 2-b and ribavirin for hepatitis C, experienced progressive painless blurring of vision in his left eye over a period of 4 days. Fundoscopy revealed pale temporal segmental edema of the optic disc and retina. Ocular examination and blood tests ruled out other disorders which could explain the visual disturbance. DISCUSSION The patient was diagnosed with an ischemic neuroretinopathy associated with interferon but, due to a favourable visual outcome, the treatment was not discontinued.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>2005 Sep </dc:date>
<dc:title xml:lang="es">Neurorretinopatía isquémica asociada a interferón.</dc:title>
<dc:title xml:lang="en">[Ischemic neuroretinopathy associated with use of interferon].</dc:title>
<dc:publisher>Archivos de la Sociedad Espanola de Oftalmologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
